With promising new therapies for amyotrophic lateral sclerosis (ALS) on the horizon, now is the time for ongoing investment in research discovery that will continue to fuel the development of treatments.
Apellis Pharmaceuticals to Host R&D Day on June 30, 2021 forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.
ALS Biomarkers in Drug Development, Upcoming Webinar Hosted by Xtalks
Share Article
In this free webinar, industry experts will provide an overview of different types of ALS biomarkers, how ALS biomarkers should be chosen based on the relevance to the mechanism of action and why their use in ALS trials should be a serious consideration. They will also discuss how some biomarkers in ALS research are more valuable than others at this time, as well as the application of ALS biomarkers in drug development.
There is a strong need for research, understanding and potential treatments in ALS. This webinar will focus on ALS biomarkers.
Posted: Mar 12, 2021 5:00 AM AT | Last Updated: March 12
Shelley Clark-Collins and her better half Mike Doyle drove from Saint John to Ottawa this week so she can get an innovative treatment for her extremely rare autoimmune disease.(Bobbi-Jean MacKinnon/CBC)
While many Canadians are wondering when they re going to get their COVID-19 vaccine, a New Brunswick woman will soon have every vaccine she has ever received wiped out of her system.
Shelley Clark-Collins, 56, of Saint John, is in Ottawa, where she will undergo a combination of intense chemotherapy and a blood stem cell transplant.
It s an innovative, aggressive and risky procedure aimed at resetting her immune system.